Category: Latest News
-
Ollie’s Bargain Outlet Shares Surge After Strong Q2 Results and Raised Outlook
Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ:OLLI) saw its stock jump 4.1% following the release of second-quarter results that exceeded analyst expectations, accompanied by an upgraded full-year forecast. The discount retailer reported adjusted earnings per share of $0.99, surpassing the consensus estimate of $0.93. Revenue totaled $679.56 million, above the anticipated $662.22 million, marking a 17.5%…
-
CEL-SCI Shares Plunge After $10 Million Public Offering Priced at Discount
CEL-SCI Corporation (AMEX:CVM) saw its stock drop 31% following the announcement of a $10 million public offering priced well below its prior closing value. The clinical-stage cancer immunotherapy company set a best-efforts public offering of 1,111,200 common shares at $9.00 each, a 31% discount to Wednesday’s closing price of $13.04. The offering is expected to…
-
Cognition Therapeutics Shares Drop Following $30 Million Direct Stock Offering
Shares of Cognition Therapeutics Inc. (NASDAQ:CGTX) declined 17% after the clinical-stage biotech company announced a $30 million registered direct offering of common stock. The offering includes the sale of 14,700,000 shares to two new institutional investors, one of which the company described as a “preeminent global investment manager.” The transaction is expected to close around…
-
Accelerant Holdings Rises Over 2% Following Strong Q2 Performance
Accelerant Holdings (NYSE:ARX), the tech company operating a data-driven risk exchange platform for the specialty insurance sector, saw its shares climb 2.15% in pre-market trading on Thursday after reporting second-quarter results that surpassed analyst expectations. The company posted adjusted earnings of $0.04 per share for the quarter ending June 30, 2025, alongside revenue of $219.1…
-
Best Buy Surpasses Q2 Expectations, Maintains Full-Year Guidance Despite Tariff Concerns
Best Buy (NYSE:BBY) reported second-quarter results that exceeded analyst projections, while reaffirming its full-year guidance amid ongoing uncertainty over tariffs. Despite the positive numbers, the retailer’s shares dipped more than 1% in pre-market trading on Thursday. The company posted earnings per share (EPS) of $1.28, beating the consensus estimate of $1.22, with revenue reaching $9.44…
-
Outlook Therapeutics Shares Plunge After FDA Rejects Wet AMD Therapy
Outlook Therapeutics (NASDAQ:OTLK) stock fell sharply, tumbling 70% in pre-market trading Thursday following the U.S. Food and Drug Administration’s (FDA) rejection of its ONS-5010/LYTENAVA (bevacizumab-vikg) application, intended as a treatment for wet age-related macular degeneration (wet AMD). The FDA issued a Complete Response Letter (CRL) for the company’s resubmitted Biologics License Application (BLA), citing a…
-
Genesco Shares Drop Over 8% Despite Sales Beat as Tariff Pressures Weigh on Profit
Genesco Inc. (NYSE:GCO) saw its shares fall 8.7% in pre-market trading Thursday after the footwear retailer reported second-quarter results that surpassed revenue expectations but were overshadowed by tariff-related profit pressures. The parent company of Journeys, Schuh, and Johnston & Murphy posted an adjusted loss of $1.14 per share for the quarter, better than the $1.25…
-
Dick’s Sporting Goods Boosts Full-Year Guidance After Strong Q2
Dick’s Sporting Goods (NYSE:DKS) delivered better-than-expected results for its second quarter on Wednesday, posting record sales and raising its outlook for the full year as consumer demand remains robust. Following the announcement, the company’s shares climbed 1.9%. The retailer reported adjusted earnings per share of $4.38, surpassing analysts’ expectations of $4.30. Revenue for the quarter…
-
Dow Jones, S&P, Nasdaq, Futures, Wall Street Braces for Volatility Ahead of Inflation Data
U.S. stock futures indicate a mostly flat open on Thursday, signaling a quiet start after the modest rally seen over the past two sessions. Investors are treading carefully as they weigh corporate earnings and upcoming economic indicators. Shares of Nvidia (NASDAQ:NVDA) fell 0.3% in pre-market trading. While the AI chipmaker exceeded second-quarter expectations overall, weaker-than-anticipated…
-
U.S. Economy Outperforms Expectations in Q2
Revised figures released Thursday by the Commerce Department indicate that the U.S. economy expanded more than initially reported in the second quarter of 2025. Real gross domestic product (GDP) surged 3.3% in Q2, exceeding the prior estimate of a 3.0% increase and surpassing economists’ expectations for a 3.1% upward revision. The Commerce Department noted that…